Advances in interventional and hybrid therapy in neonatal congenital heart disease

Seminars in Fetal and Neonatal Medicine

Volumn 18, Issue 5, 2013, Pages 311-321

  Schranz, Dietmar ^a   Michel Behnke, Ina ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Hybrid procedure; Newborns and infants; Transcatheter approach

Indexed keywords

AORTA COARCTATION; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; AORTOPULMONARY SHUNT; ARTICLE; BALLOON DILATATION; BRAIN INJURY; CARDIOGENIC SHOCK; CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASE; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; CYANOSIS; DUCTUS ARTERIOSUS; FALLOT TETRALOGY; FOLLOW UP; HEART ATRIUM SEPTUM DEFECT; HEART EJECTION FRACTION; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; LONG TERM CARE; LONG TERM SURVIVAL; LUNG BLOOD FLOW; LUNG CIRCULATION; LUNG VEIN DRAINAGE ANOMALY; NORWOOD PROCEDURE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTNATAL CARE; PROSTAGLANDIN BLOOD LEVEL; PULMONARY SHUNT; PULMONARY VALVE ATRESIA; PULMONARY VALVE INSUFFICIENCY; RISK FACTOR; SELF EXPANDING STENT; SURVIVAL RATE; SYSTEMIC CIRCULATION; TACHYPNEA; TRANSLUMINAL VALVULOPLASTY; VALVULOPLASTY;

HYBRID PROCEDURE; NEWBORNS AND INFANTS; TRANSCATHETER APPROACH;

CARDIAC CATHETERIZATION; CARDIAC SURGICAL PROCEDURES; COMBINED MODALITY THERAPY; HEART; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; POSTOPERATIVE COMPLICATIONS;

EID: 84884355740     PISSN: 1744165X     EISSN: 18780946     Source Type: Journal    
DOI: 10.1016/j.siny.2013.05.005     Document Type: Article

References (83)

1. Rashkind W.J., Gibson J. Interventional cardiac catheterization in congenital heart disease. Int J Cardiol 1985, 7:1-11.
2. Feltes T.F., Bacha E., Beekman R.H., et al. Indications for cardiac catheterization and intervention in pediatric cardiac disease; a scientific statement from the American Heart Association. Circulation 2011, 123:2607-2652.
3. Qureshi S.A., Benson L. Congenital heart disease. Future Cardiol 2012, 8:143-147.
4. Rashkind W.J., Miller W.W. Creation of an atrial septal defect without thoracotomy. A palliative approach to complete transposition of the great arteries. JAMA 1966, 196:991-992.
5. Petit C.J., Rome J.J., Wernovsky G., et al. Preoperative brain injury in transposition of the great arteries is associated with oxygenation and time to surgery, not balloon atrial septostomy. Circulation 2009, 119:709-716.
6. Zellers T.M., Dixon K., Moake L., Wright J., Ramaciotti C. Bedside balloon atrial septostomy is safe, efficacious, and cost-effective compared with septostomy performed in the cardiac catheterization laboratory. Am J Cardiol 2002, 89:613-615.
7. Kan J.S., White R.I., Mitchell S.E., Gardner T.J. Percutaneous balloon valvuloplasty: a new method for treating congenital pulmonary-valve stenosis. NEngl J Med 1982, 307:540-542.
8. Shaath G., Mutairi M.A., Tamimi O., Alakhfash A., Abolfotouh M., Alhabshan F. Predictors of reintervention in neonates with critical pulmonary stenosis or pulmonary atresia with intact ventricular septum. Cardiol Young 2012, 22:227-229.
9. Alwi M. Management algorithm in pulmonary atresia with intact ventricular septum. Catheter Cardiovasc Intervent 2006, 67:679-686.
10. Bondanza S., Derchi M., Tuo G., Zannini L., Marasini M. Use of a telescopic system for transcatheter radiofrequency perforation and balloon valvotomy in infants with pulmonary atresia and intact ventricular septum. Cardiol Young 2012, 26:1-6.
11. Alwi M., Budi R.R., Mood M.C., Leong M.C., Samion H. Pulmonary atresia with intact septum: the use of Conquest Pro coronary guidewire for perforation of atretic valve and subsequent interventions. Cardiol Young 2012, 29:1-6.
12. Lamers L., Garn B., Ellsworth E., Graziano J.N. Decreased incidence of right-ventricular outflow tract complications using a retrograde snare technique for radiofrequency pulmonary valve perforation. Pediatr Cardiol 2012, 33:1275-1280.
13. Michel-Behnke I., Akintuerk H., Thul J., Bauer J., Hagel K.J., Schranz D. Stent implantation in the ductus arteriosus for pulmonary blood supply in congenital heart disease. Catheter Cardiovasc Intervent 2004, 61:242-252.
14. Alwi M., Choo K.K., Radzi N.A., Samion H., Pau K.K., Hew C.C. Concomitant stenting of the patent ductus arteriosus and radiofrequency valvotomy in pulmonary atresia with intact ventricular septum and intermediate right ventricle: early in-hospital and medium-term outcomes. JThorac Cardiovasc Surg 2011, 141:1355-1361.
15. Chubb H., Pesonen E., Sivasubramanian S., et al. Long-term outcome following catheter valvotomy for pulmonary atresia with intact ventricular septum. JAm Coll Cardiol 2012, 59:1468-1476.
16. Li S., Chen W., Zhang Y., et al. Hybrid therapy for pulmonary atresia with intact ventricular septum. Ann Thorac Surg 2011, 91:1467-1471.
17. Blalock A., Taussig H. The surgical treatment of malformations of the heart in which there is pulmonary stenosis or pulmonary atresia. JAMA 1945, 128:189-202.
18. Al Jubair K.A., AlFagih M.R., Jarallah A.S., et al. Results of 546 Blalock-Taussig shunts performed in 478 patients. Cardiol Young 1998, 8:486-490.
19. Gibbs J.L. Ductal stenting for restricted pulmonary blood flow in neonates: 15 years on but still a very limited place in clinical practice. Heart 2008, 94:834-835.
20. Alwi M., Choo K.K., Latiff H.A., Kandavello G., Samion H., Mulyadi M.D. Initial results and medium-term follow-up of stent implantation of patent ductus arteriosus in duct-dependent pulmonary circulation. JAm Coll Cardiol 2004, 44:438-445.
21. Mahesh K., Kannan B.R., Vaidyanathan B., Kamath P., Anil S.R., Kumar R.K. Stenting the patent arterial duct to increase pulmonary blood flow. Indian Heart J 2005, 57:704-708.
22. Quereshi S.A. Catheterization in neonates with pulmonary atresia with intact ventricular septum. Catheter Cardiovasc Intervent 2006, 67:924-931.
23. Santoro G., Gaio G., Palladino M.T., et al. Stenting of the arterial duct in newborns with duct-dependent pulmonary circulation. Heart 2008, 94:925-929.
24. Gewillig M., Boshoff D.E., Dens J., Mertens L., Benson L.N. Stenting the neonatal arterial duct in duct-dependent pulmonary circulation: new techniques, better results. JAm Coll Cardiol 2004, 43:107-112.
25. Santoro G., Capozzi G., Cainiello G., et al. Pulmonary artery growth after palliation of congenital heart disease with duct-dependent pulmonary circulation. JAm Coll Cardiol 2009, 54:2180-2186.
26. Schranz D., Michel-Behnke I., Heyer R., et al. Stent implantation of the arterial duct in newborns with truly duct-dependent pulmonary circulation: a single center experience with emphasis on aspects of the interventional technique. JIntervent Cardiol 2010, 23:581-588.
27. Boshoff D.E., Michel-Behnke I., Schranz D., Gewillig M. Stenting the neonatal duct. Expert Rev Cardiovasc Ther 2007, 5:893-901.
28. Schranz D. Stenting the arterial duct. Complications during percutaneous interventions for congenital and structural heart diseases 2009, 131-144. Informa Healthcare, London. Z.M. Hijazi, T. Feldman, J.P. Cheatham, H. Sievert (Eds.).
29. Schranz D., Michel-Behnke I. Axillary artery access for cardiac interventions in newborns. Ann Pediatr Cardiol 2008, 1:126-130.
30. Schneider M., Zartner P., Sidiropoulos A., Konertz W., Hausdorf G. Stent implantation of the arterial duct in newborns with duct-dependent circulation. Eur Heart J 1998, 19:1401-1409.
31. Alwi M. Stenting the patent ductus arteriosus in duct-dependent pulmonary circulation: techniques, complications and follow-up issues. Future Cardiol 2012, 8:237-250.
32. Matsui H., Mellander M., Roughton M., Jicinska H., Gardiner H.M. Morphological and physiological predictors of fetal aortic coarctation. Circulation 2008, 118:1793-1801.
33. McElhinney D.B., Tworetzky W., Lock J.E. Current status of fetal cardiac intervention. Circulation 2010, 121:1256-1263.
34. Kohl T. Chronic intermittent materno-fetal hyperoxygenation in late gestation may improve on hypoplastic cardiovascular structures associated with cardiac malformations in human fetuses. Pediatr Cardiol 2010, 31:250-263.
35. Barron D.J., Kilby M.D., Davies B., Wright J.G., Jones T.J., Brawn W.J. Hypoplastic left heart syndrome. Lancet 2009, 374:551-554.
36. Mahle W., Spray T., Wernovsky G., Gaynor J., Cark B. Staged reconstruction for hypoplastic left heart syndrome: a 15-year experience from a single institution. Circulation 2000, 102:136-141.
37. Tweddell J.S., Hoffman G.M., Mussatto K.A., et al. Improved survival of patients undergoing palliation of hypoplastic left heart syndrome: lessons learned from 115 consecutive patients. Circulation 2002, 106:82-89.
38. Stasik C.N., Gelehrter S., Goldberg C.S., Bove E.L., Devaney E.J., Ohye R.G. Current outcomes and risk factors for the Norwood procedure. JThorac Cardiovasc Surg 2006, 131:412-441.
39. Rychik J., Rome J.J., Collins M.H., DeCampli W.M., Spray T.L. The hypoplastic left heart syndrome with intact atrial septum: atrial morphology, pulmonary vascular histopathology and outcome. JAm Coll Cardiol 1999, 34:554-560.
40. Gossett J.G., Rocchini A.P., Lloyd T.R., Graziano J.N. Catheter-based decompression of the left atrium in patients with hypoplastic left heart syndrome and restrictive atrial septum is safe and effective. Catheter Cardiovasc Intervent 2006, 67:619-624.
41. Glatz J.A., Tabbutt S., Gaynor J.W., et al. Hypoplastic left heart syndrome with atrial level restriction in the era of prenatal diagnosis. Ann Thorac Surg 2007, 84:1633-1638.
42. Atz A.M., Feinstein J.A., Jonas R.A., Perry S.B., Wessel D.L. Preoperative management of pulmonary venous hypertension in hypoplastic left heart syndrome with restrictive atrial septal defect. Am J Cardiol 1999, 83:1224-1228.
43. Seale A.N., Uemura H., Webber S.A., et al. Total anomalous pulmonary venous connection. Circulation 2010, 122:2718-2726.
44. Kelle A.M., Backer C.L., Gossett J.G., Kaushal S., Mavouridis C. Total anomalous pulmonary venous connection: results of surgical repair of 100 patients at a single institution. JThorac Cardiovasc Surg 2010, 139:1387-1394.
45. Frommelt P.C., Sheridan D.C., Deadtman S., et al. Unobstructive total anomalous pulmonary venous return: impact of early elective repair on the need for prolonged mechanical ventilatory support. Pediatr Cardiol 2010, 31:1191-1197.
46. Valsangiacomo E.R., Hornberger L.K., Barrea C., Smallhorn J.F., Yoo S.J. Partial and total anomalous pulmonary venous connection in the fetus: two-dimensional and Doppler echocardiographic findings. Ultrasound Obstet Gynecol 2003, 22:257-263.
47. Rupp S., Michel-Behnke I., Valeske K., Akintürk H., Schranz D. Implantation of stents to ensure an adequate interatrial communication in patients with hypoplastic left heart syndrome. Cardiol Young 2007, 17:535-540.
48. Iyad A.-A., Petit C., Gillespie J.J. Comparison between stenting and balloon interventions for intact or restrictive atrial septum in hypoplastic left heart syndrome. Catheter Cardiovasc Intervent 2006, 67:837.
49. Xu Z., Owens G., Gordon D., Cain C., Ludomirsky A. Non invasive creation of an atrial septal defect by histotripsy in a canine model. Circulation 2010, 121:742-749.
50. Schranz D., Jux C., Akintuerk H. Novel catheter-interventional strategy for intracardiac connecting of total anomalous pulmonary venous return (TAPVR) in newborns with hypoplastic left heart-syndrome (HLHS) prior to hybrid approach. Catheter Cardiovasc Intervent 2012 Dec 17, [Epub ahead of print]. 10.1002/ccd.24783.
51. Marshall A.C., van der Velde M.E., Tworetzky W., et al. Creation of an atrial septal defect in utero for fetuses with hypoplastic left heart syndrome and intact or highly restrictive atrial septum. Circulation 2004, 110:253-258.
52. Edwards A., Menahem S., Veldman A., et al. Fetal cardiac catheterization using a percutaneous transhepatic access technique: preliminary experience in a lamb model. Ultrasound Obstet Gynecol 2012 Nov 23, [Epub ahead of print]. 10.1002/uog.12352.
53. Lababidi Z., Wu J.R., Walls J.T. Percutaneous balloon aortic valvuloplasty: results in 23 patients. Am J Cardiol 1984, 53:194-197.
54. McCrindle B.W., Blackstone E.H., Williams W.G., et al. Are outcomes of surgical versus transcatheter balloon valvotomy equivalent in neonatal critical aortic stenosis?. Circulation 2001, 104(Suppl. 1):I-152-I-158.
55. Latiff H.A., Sholler G.F., Cooper S. Balloon dilatation of aortic stenosis in infants younger than 6 months of age: intermediate outcome. Pediatr Cardiol 2003, 24:17-26.
56. Pedra C.A., Sidhu R., McCrindle B.W., et al. Outcomes after balloon dilation of congenital aortic stenosis in children and adolescents. Cardiol Young 2004, 14:315-321.
57. Reich O., Tax P., Marek J., et al. Long term results of percutaneous balloon valvoplasty of congenital aortic stenosis: independent predictors of outcome. Heart 2004, 90:70-76.
58. McElhinney D.B., Lock J.E., Keane J.F., Moran A.M., Colan S.D. Left heart growth, function, and reintervention after balloon aortic valvuloplasty for neonatal aortic stenosis. Circulation 2005, 111:451-458.
59. Fratz S., Gildein H.P., Balling G., et al. Aortic valvuloplasty in pediatric patients substantially postpones the need for aortic valve surgery: a single-center experience of 188 patients after up to 17.5 years of follow-up. Circulation 2008, 117:1201-1206.
60. Magee A.G., Nykanen D., McCrindle B.W., Wax D., Freedom R.M., Benson L.N. Balloon dilation of severe aortic stenosis in the neonate: comparison of anterograde and retrograde catheter approaches. JAm Coll Cardiol 1997, 30:1061-1066.
61. Bonow R.O., Carabello B.A., Kanu C., et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease). Circulation 2006, 114:e84-e231. [published corrections appear in Circulation 2007;115:e409 and Circulation 2010;121:e443].
62. De Giovanni J.V., Edgar R.A., Cranston A. Adenosine induced transient cardiac standstill in catheter interventional procedures for congenital heart disease. Heart 1998, 80:330-333.
63. Kahn R.A., Moskowitz D.M., Marin M.L., et al. Safety and efficacy of high-dose adenosine-induced asystole during endovascular AAA repair. JEndovasc Ther 2000, 7:292-296.
64. Daehnert I., Rotzsch C., Wiener M., Schneider P. Rapid right ventricular pacing is an alternative to adenosine in catheter interventional procedures for congenital heart disease. Heart 2004, 90:1047-1050.
65. David F., Sánchez A., Yánez L., et al. Cardiac pacing in balloon aortic valvuloplasty. Int J Cardiol 2007, 116:327-330.
66. Bower C., Ramsay J.M. Congenital heart disease: a 10-year cohort. JPaediatr Child Health 1994, 30:414-418.
67. Zakuwa T.M.H., Rowe R.D. Structural heart disease in the newborn. Arch Dis Child 1979, 54:281-285.
68. Cohen M., Fuster V., Steele P.M., Driscoll D., McGoon D.C. Coarctation of the aorta: long-term follow-up and prediction of outcome after surgical correction. Circulation 1989, 80:840-845.
69. Heger M., Willfort A., Neunteufl T., et al. Vascular dysfunction after coarctation repair is related to the age at surgery. Int J Cardiol 2005, 99:295-299.
70. Senzaki H., Iwamoto Y., Ishido H., et al. Ventricular-vascular stiffening in patients with repaired coarctation of aorta: integrated pathophysiology of hypertension. Circulation 2008, 118(14 Suppl):S191-S198.
71. Bouzguenda I., Marini D., Ou P., Boudjemline Y., Bonnet D., Agnoletti G. Percutaneous treatment of neonatal aortic coarctation presenting with severe left ventricular dysfunction as a bridge to surgery. Cardiol Young 2009, 19:244-251.
72. Rothman A., Galindo A., Evans W.N., Collazos J.C., Restrepo H. Effectiveness and safety of balloon dilation of native aortic coarctation in premature neonates weighing < or= 2,500grams. Am J Cardiol 2010, 105:1176-1180.
73. Schranz D., Zartner P., Michel-Behnke I., Akintürk H. Bioabsorbable metal stents for percutaneous treatment of critical re-coarctation of the aorta in a newborn. Catheter Cardiovasc Intervent 2006, 67:671-673.
74. Akintürk H., Michel-Behnke I., Valeske K., et al. Hybrid transcatheter-surgical palliation: basis for univentricular or biventricular repair: the Giessen experience. Pediatr Cardiol 2007, 28:79-87.
75. Akintuerk H., Michel-Behnke I., Valeske K., et al. Stenting of the arterial duct and banding of the pulmonary arteries: basis for combined Norwood stage I and II repair in hypoplastic left heart. Circulation 2002, 105:1099-1103.
76. Venugopal P.S., Luna K.P., Anderson D.R., et al. Hybrid procedure as an alternative to surgical palliation of high-risk infants with hypoplastic left heart syndrome and its variants. JThorac Cardiovasc Surg 2010, 139:1211-1215.
77. Galantowicz M., Cheatham J.P. Lessons learned from the development of a new hybrid strategy for the management of hypoplastic left heart syndrome. Pediatr Cardiol 2005, 26:190-199.
78. Michel-Behnke I., Akintuerk H., Marquardt I., et al. Stenting of the ductus arteriosus and banding of the pulmonary arteries: basis for various surgical strategies in newborns with multiple left heart obstructive lesions. Heart 2003, 89:645-650.
79. Schranz D. Stenting the arterial duct. Complications during percutaneous interventions for congenital and structural heart disease 2009, Informa Healthcare, London. Z. Hijazi, T. Feldman, J.P. Cheatham, H. Sievert (Eds.).
80. Gutgesell H.P., Lim D.S. Hybrid palliation in hypoplastic left heart syndrome. Curr Opin Cardiol 2007, 22:55-59.
81. Ohye R.G., Sleeper L.A., Mahony L., et al. Pediatric Heart Network Investigators. Comparison of shunt types in the Norwood procedure for single-ventricle lesions. NEngl J Med 2010, 362:1980-1992.
82. Baba K., Kotani Y., Chetan D., et al. Hybrid versus Norwood strategies for single-ventricle palliation. Circulation 2012, 126(11 Suppl. 1):S123-S131.
83. Galantowicz M., Cheatham J.P., Phillips A., et al. Hybrid approach for hypoplastic left heart syndrome: intermediate results after the learning curve. Ann Thorac Surg 2008, 85:2063-2070.